Literature DB >> 27394919

In vivo Target Residence Time and Kinetic Selectivity: The Association Rate Constant as Determinant.

Wilhelmus E A de Witte1, Meindert Danhof1, Piet H van der Graaf2, Elizabeth C M de Lange3.   

Abstract

It is generally accepted that, in conjunction with pharmacokinetics, the first-order rate constant of target dissociation is a major determinant of the time course and duration of in vivo target occupancy. Here we show that the second-order rate constant of target association can be equally important. On the basis of the commonly used mathematical models for drug-target binding, it is shown that a high target association rate constant can increase the (local) concentration of the drug, which decreases the rate of decline of target occupancy. The increased drug concentration can also lead to increased off-target binding and decreased selectivity. Therefore, the kinetics of both target association and dissociation need to be taken into account in the selection of drug candidates with optimal pharmacodynamic properties.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Keywords:  association rate constant; in vivo; kinetic selectivity; pharmacokinetics; target binding kinetics; target-mediated drug disposition

Mesh:

Substances:

Year:  2016        PMID: 27394919     DOI: 10.1016/j.tips.2016.06.008

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  27 in total

1.  Quantitative systems pharmacology analysis of drug combination and scaling to humans: the interaction between noradrenaline and vasopressin in vasoconstriction.

Authors:  Anyue Yin; Akihiro Yamada; Wiro B Stam; Johan G C van Hasselt; Piet H van der Graaf
Journal:  Br J Pharmacol       Date:  2018-07-10       Impact factor: 8.739

2.  Role of Molecular Interactions and Protein Rearrangement in the Dissociation Kinetics of p38α MAP Kinase Type-I/II/III Inhibitors.

Authors:  Wanli You; Chia-En A Chang
Journal:  J Chem Inf Model       Date:  2018-04-16       Impact factor: 4.956

Review 3.  Chaperome heterogeneity and its implications for cancer study and treatment.

Authors:  Tai Wang; Anna Rodina; Mark P Dunphy; Adriana Corben; Shanu Modi; Monica L Guzman; Daniel T Gewirth; Gabriela Chiosis
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

Review 4.  Adapting to stress - chaperome networks in cancer.

Authors:  Suhasini Joshi; Tai Wang; Thaís L S Araujo; Sahil Sharma; Jeffrey L Brodsky; Gabriela Chiosis
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

5.  Luciferase Complementation Approaches to Measure GPCR Signaling Kinetics and Bias.

Authors:  Nicola C Dijon; Desislava N Nesheva; Nicholas D Holliday
Journal:  Methods Mol Biol       Date:  2021

Review 6.  Link between a high k on for drug binding and a fast clinical action: to be or not to be?

Authors:  Georges Vauquelin
Journal:  Medchemcomm       Date:  2018-08-16       Impact factor: 3.597

7.  The implications of target saturation for the use of drug-target residence time.

Authors:  Wilhelmus E A de Witte; Meindert Danhof; Piet H van der Graaf; Elizabeth C M de Lange
Journal:  Nat Rev Drug Discov       Date:  2018-12-28       Impact factor: 84.694

8.  The 3D Brain Unit Network Model to Study Spatial Brain Drug Exposure under Healthy and Pathological Conditions.

Authors:  Esmée Vendel; Vivi Rottschäfer; Elizabeth C M de Lange
Journal:  Pharm Res       Date:  2020-07-09       Impact factor: 4.200

9.  Distinct in vivo target occupancy by bivalent- and induced-fit-like binding drugs.

Authors:  Georges Vauquelin
Journal:  Br J Pharmacol       Date:  2017-10-18       Impact factor: 8.739

Review 10.  Perspective: Implications of Ligand-Receptor Binding Kinetics for Therapeutic Targeting of G Protein-Coupled Receptors.

Authors:  Wijnand J C van der Velden; Laura H Heitman; Mette M Rosenkilde
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.